Ionis Pharmaceuticals
IONS
IONS
351 hedge funds and large institutions have $5.61B invested in Ionis Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 119 increasing their positions, 118 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more funds holding
Funds holding: 349 → 351 (+2)
10% less capital invested
Capital invested by funds: $6.22B → $5.61B (-$611M)
15% less call options, than puts
Call options by funds: $26.1M | Put options by funds: $30.5M
Holders
351
Holding in Top 10
4
Calls
$26.1M
Puts
$30.5M
Top Buyers
| 1 | +$127M | |
| 2 | +$61.7M | |
| 3 | +$61.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$49.5M |
| 5 |
BlackRock
New York
|
+$29.8M |
Top Sellers
| 1 | -$69.5M | |
| 2 | -$58.2M | |
| 3 | -$38.7M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$30M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$23.9M |